Skip to main content
Signal8

REGENERON PHARMACEUTICALS, INC. (REGN)

Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization, diabetic retinopathy, and macular edema resulting from retinal vein occlusion (both central and branch). Other significant offerings are Dupixent, an injectable solution for atopic dermatitis and asthma in both adults and pediatric patients; Libtayo, indicated for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent, an injection prescribed for adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease; REGEN-COV for COVID-19; and Kevzara, a solution targeting rheumatoid arthritis in adult patients. Furthermore, Regeneron provides Inmazeb for infections caused by Zaire ebolavirus; ARCALYST, an injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and Muckle-Wells syndrome; and ZALTRAP, an intravenous infusion used in the treatment of metastatic colorectal cancer. In addition to its existing product lineup, the company is actively engaged in developing novel product candidates aimed at addressing unmet medical needs in areas such as ocular diseases, allergic and inflammatory conditions, cardiovascular and metabolic disorders, infectious diseases, rare diseases, cancer, pain management, and hematologic conditions. Regeneron maintains extensive collaboration and licensing agreements with a diverse range of partners, including Sanofi, Bayer, Teva Pharmaceutical Industries Ltd., Mitsubishi Tanabe Pharma Corporation, Alnylam Pharmaceuticals, Inc., Roche Pharmaceuticals, and Kiniksa Pharmaceuticals, Ltd. It also holds agreements with entities such as the U.S. Department of Health and Human Services, Zai Lab Limited, Intellia Therapeutics, Inc., the Biomedical Advanced Research Development Authority, and AstraZeneca PLC. The company was founded in 1988 and its corporate headquarters are situated in Tarrytown, New York.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGNHealthcare
+0.24%$954.65
Mkt Cap$98.76B
EV$94.88B
Float96.23M
O/S103.45M
VOL358K sh
$ Vol$342.71M
RVOL0.37×
Inst Own85.8%
SI2.3%
Net Cash/Sh+$57.03
Div Yield0.39%
Dilution
Regeneron Pharmaceuticals, Inc. logoNASDAQ:REGN$954.65+0.24%
Financials Summary
Revenue$14.34B
Net Income$4.5B
Total Assets$40.56B
Free Cash Flow$4.08B
Debt & Equity
Debt 8%
Equity 92%
Total Debt$2.71B
Total Equity$31.26B
Shares Outstanding
Short Interest

No short interest data available.

Split History

No splits on record

Nothing in REGN's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$40.56B
Liabilities$9.3B
Accounts Receivable$5.74B
Accounts Payable$939M
Inventory$3.2B
PP&E (Net)$5.12B
Goodwill$0
Intangible Assets$1.26B
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996FY 1995FY 1994FY 1993FY 1992FY 1991FY 1990
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-31
Revenue$14.34B$14.2B$13.12B$12.17B$16.07B$8.5B$6.56B$6.71B$5.87B$4.86B$4.1B$2.82B$2.1B$1.38B$445.82M$459.07M$379.27M$238.46M$125.02M$63.45M$66.19M$174.02M$57.5M$21.99M$21.97M$59.28M$34.5M$38.2M$33.1M$24.1M$27.4M$23.2M$10.6M$11.5M$7.3M$5M
YoY Growth1.0%8.3%7.8%-24.3%89.1%29.6%-2.3%14.3%20.8%18.4%45.5%34.0%52.7%209.2%-2.9%21.0%59.1%90.7%97.1%-4.1%-62.0%202.7%161.5%0.1%-62.9%71.8%-9.7%15.4%37.3%-12.0%18.1%118.9%-7.8%57.5%46.0%-
Cost of Revenue$2.1B$1.97B$2.24B$1.71B$2.72B$1.36B$975.4M$582.3M$542.53M$404.44M$467.62M$257.7M$196.56M$121.39M$35.3M$21.78M$15.93M$12.21M$0$22.74M$25.06M$151.31M$6.68M$6.48M$6.51M$15.57M$3.6M$5M$2.6M$1.1M$0$0$0$0$12.8M$6.3M
Gross Profit$12.24B$12.23B$10.87B$10.47B$13.35B$7.14B$5.58B$6.13B$5.33B$4.46B$3.64B$2.56B$1.91B$1.26B$410.53M$437.29M$363.33M$226.25M$0$40.71M$41.13M$22.71M$50.82M$15.51M$15.46M$43.71M$30.9M$33.2M$30.5M$23M$27.4M$23.2M$10.6M$11.5M-$5.5M-$1.3M
Gross Margin85.4%86.1%82.9%86.0%83.1%84.0%85.1%91.3%90.8%91.7%88.6%90.9%90.7%91.2%92.1%95.3%95.8%94.9%-64.2%62.1%13.0%88.4%70.5%70.4%73.7%89.6%86.9%92.1%95.4%100.0%100.0%100.0%100.0%-75.3%-26.0%
Research and Development$5.85B$5.23B$3.99B$3.06B$2.62B$2.5B$2.24B$2.04B$1.93B$1.95B$1.55B$1.22B$818.74M$588.61M$498.42M$469.56M$384.51M$266.73M$190.13M$122.12M$137.92M$136.09M$136.02M$124.93M$91.54M$56.26M$44.9M$37M$27.8M$28.3M$23.3M$39.7M$0$0$0$0
Selling, General, and Administrative$2.7B$2.95B$2.54B$2.12B$1.82B$1.35B$1.34B$1.56B$1.32B$1.18B$838.53M$504.75M$328.92M$207.96M$117.26M$65.2M$52.92M$49.35M$37.87M$25.89M$25.42M$17.06M$14.79M$12.53M$9.61M$8.31M$6.4M$5.8M$5.8M$5.9M$5.8M$8.5M$46.3M$27.8M$3.3M$1.7M
Other$114.1M$53.4M-$2.1M-$89.9M-$45.6M-$280.4M-$209.2M$0$0$0$0-$1.2B-$801.26M$0$0$0$0$0$11.49M$0$0-$136.09M$0$0$0$4.42M$3.4M$3M$4.4M$6.1M$5.9M$4.2M$3.1M$2M$800K$300K
Total Operating Expenses$8.66B$8.24B$6.52B$5.08B$4.4B$3.56B$3.37B$3.59B$3.25B$3.13B$2.38B$1.72B$1.15B$796.57M$615.68M$534.77M$437.44M$316.08M$227.99M$148.02M$163.34M$17.06M$150.81M$137.46M$101.15M$68.99M$54.7M$45.8M$38M$40.3M$35M$52.4M$49.4M$29.8M$4.1M$2M
Operating Income (EBIT)$3.58B$3.99B$4.35B$5.39B$8.95B$3.58B$2.21B$2.53B$2.08B$1.33B$1.25B$823.92M$743.05M$460.51M-$205.16M-$97.47M-$74.1M-$89.83M-$114.45M-$107.31M-$124.42M$5.65M-$99.99M-$121.95M-$85.68M-$25.28M-$23.8M-$12.5M-$7.5M-$17.3M-$7.6M-$29.2M-$38.8M-$18.3M-$9.6M-$3.3M
Operating Margin24.9%28.1%33.2%44.2%55.7%42.1%33.7%37.8%35.4%27.4%30.5%29.2%35.3%33.4%-46.0%-21.2%-19.5%-37.7%-91.5%-169.1%-188.0%3.2%-173.9%-554.6%-389.9%-42.6%-69.0%-32.7%-22.7%-71.8%-27.7%-125.9%-366.0%-159.1%-131.5%-66.0%
Interest Expense$43.8M$55.2M$73M$59.4M$57.3M$56.9M$30.2M$28.2M$25.12M$7.2M$14.24M$37.37M$46.44M$45.3M$21.28M$9.12M$2.34M$7.75M$12.04M$0$0$0$0$0$0$4.58M$0$0$3.4M$14.3M$14.7M$0$0$0$0$0
Interest Income$716.8M$711.4M$495.9M$160.1M$0$0$0$0$0$0$6.28M$5.76M$2.67M$2.01M$3.55M$2.02M$4.39M$20.66M$26.8M$16.55M$10.38M$5.48M$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)$1.65B$789.2M-$149.3M-$526.8M$379M$233.8M$219.3M$19.1M-$1.08M-$926K-$26.82M-$62.68M-$47.17M-$46.09M-$17.73M-$7M$2.15M$9.47M$8.85M$4.16M$26.76M$36.05M-$7.47M-$2.42M$9.5M$25.28M$23.8M$12.5M$6.2M$0$0$29.2M$38.8M$18.3M$0$3.3M
Income Before Tax (EBT)$5.23B$4.78B$4.2B$4.86B$9.33B$3.81B$2.43B$2.55B$2.08B$1.33B$1.23B$775.75M$713.36M$414.42M-$222.89M-$104.47M-$71.95M-$80.36M-$93.56M-$91.11M$124.42M$53.87M-$95.53M-$112.52M-$73.52M-$29.85M-$22.8M-$8.2M-$7.5M-$17.3M-$7.6M$0$0$0-$4.4M$0
Income Tax Expense$725.8M$367.3M$245.7M$520.4M$1.25B$297.2M$313.3M$109.1M$880M$434.29M$589.04M$427.67M$289M-$335.85M-$1.13M$0-$4.12M$2.35M-$29.75M-$21.87M$178.85M-$84.28M$3.01M-$7.01M-$21.66M$2.51M-$1.7M-$8.4M$7.5M$29.4M$30.6M$1.5M$1.1M$800K-$10.3M$0
Net Income$4.5B$4.41B$3.95B$4.34B$8.08B$3.51B$2.12B$2.44B$1.2B$895.52M$636.06M$348.07M$424.36M$750.27M-$221.76M-$104.47M-$67.83M-$82.71M-$105.6M-$102.34M-$95.45M$41.7M-$107.46M-$124.38M-$76.18M-$23.21M-$23.1M-$8.6M-$11.6M-$32.4M-$23.5M-$30.7M-$39.9M-$19.1M-$4.5M-$3.3M
Net Income Margin31.4%31.1%30.1%35.6%50.2%41.3%32.3%36.4%20.4%18.4%15.5%12.3%20.2%54.4%-49.7%-22.8%-17.9%-34.7%-84.5%-161.3%-144.2%24.0%-186.9%-565.7%-346.7%-39.2%-67.0%-22.5%-35.0%-134.4%-85.8%-132.3%-376.4%-166.1%-61.6%-66.0%
Supplementary Data
EPS43.0740.9037.0540.5176.4032.6519.3821.2911.278.556.173.364.237.92-2.45-1.26-0.85-1.05-1.59-1.77-1.710.75-2.13-2.83-1.81-0.66-0.74-0.28-0.40-1.32-1.19-1.62-2.41-1.24-0.29-0.21
Diluted EPS41.4838.3434.7738.2271.9730.5218.4621.2910.347.705.522.983.726.75-2.45-1.26-0.85-1.05-1.59-1.77-1.710.74-2.13-2.83-1.81-0.66-0.73-0.28-0.40-1.32-1.19-1.62-2.41-1.24-0.29-0.21
Weighted Average OS104.60M107.90M106.70M107.10M105.70M107.60M109.20M114.80M115.90M116.25M115.23M113.41M111.22M111.07M90.61M82.93M79.78M78.83M66.33M57.97M55.95M55.42M50.45M43.95M42.09M35.17M31.22M30.71M29.00M24.46M19.75M18.95M16.56M15.40M15.52M15.36M
EBITDA$5.82B$5.32B$4.69B$5.26B$9.67B$4.1B$2.67B$2.73B$2.25B$1.44B$1.31B$865.8M$801M$496.67M-$170.53M-$75.66M-$55.37M-$61.32M-$82.07M-$76.52M-$67.9M$69.24M-$91.51M-$113.5M-$79.61M-$20.86M-$20.4M-$9.5M-$9.3M-$11.2M-$1.7M-$25M-$35.7M-$16.3M-$8.8M-$3M
EBITDA Margin40.6%37.4%35.8%43.2%60.2%48.3%40.7%40.7%38.3%29.7%32.0%30.7%38.1%36.0%-38.3%-16.5%-14.6%-25.7%-65.6%-120.6%-102.6%39.8%-159.2%-516.2%-362.3%-35.2%-59.1%-24.9%-28.1%-46.5%-6.2%-107.8%-336.8%-141.7%-120.5%-60.0%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996FY 1995FY 1994FY 1993FY 1992FY 1991FY 1990
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-31
Assets
Current Assets
Cash and Cash Equivalents$3.12B$2.49B$2.73B$3.11B$2.89B$2.19B$1.62B$1.47B$812.73M$535.2M$809.1M$648.72M$535.61M$230.28M$483.61M$112.57M$207.07M$247.8M$498.93M$237.88M$184.51M$101.23M$118.28M$80.08M$247.39M$30.98M$23.7M$19.8M$28.9M$34.5M$32.7M$23.6M$12.5M$16.4M$26.2M$21.8M
Short-Term Investments$5.49B$6.52B$8.11B$4.64B$2.81B$1.39B$1.6B$1.34B$596.85M$503.48M$236.12M$251.76M$158.38M$77.82M$43.33M$136.8M$134.25M$226.95M$267.53M$221.4M$114.04M$194.75M$175.49M$184.19M$137.69M$86.63M$42.5M$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$8.61B$9.01B$10.84B$7.74B$5.69B$3.59B$3.21B$2.81B$1.41B$1.04B$1.05B$900.48M$693.98M$308.1M$526.94M$249.37M$341.33M$474.75M$766.46M$459.28M$298.55M$295.98M$293.77M$264.27M$385.08M$117.61M$66.2M$19.8M$28.9M$34.5M$32.7M$23.6M$12.5M$16.4M$26.2M$21.8M
Accounts Receivable$5.74B$6.21B$5.67B$5.33B$6.04B$4.11B$2.79B$2.24B$1.97B$1.61B$1.47B$976.37M$954.97M$693.12M$103.03M$81.92M$65.57M$35.21M$18.32M$7.49M$36.52M$43.1M$15.53M$4.02M$2.98M$13.84M$600K$5.7M$6.6M$4.3M$2.7M$1.7M$1.7M$1.1M$1.4M$200K
Inventory$3.2B$3.09B$2.58B$2.4B$1.95B$1.92B$1.42B$1.15B$726.14M$399.36M$238.58M$128.86M$70.35M$28.64M$13.56M-$15.14M$0$0$0$0$2.9M$3.23M$9.01M$6.83M$3.97M$1.92M$4.6M$0$0$0$0$0$0$0$0$0
Other Current Assets$474.8M$349.2M$386.6M$0$0$0$0$0$0$0$0$0$44.68M$148.13M$0$0$0$0$0$0$0$0$0$0$0$0$1.6M$67.4M$64.1M$46.2M$13.8M$26.7M$77.6M$67.2M$79M$400K
Total Current Assets$18.02B$18.66B$19.48B$15.88B$14.01B$9.78B$7.69B$7.96B$5.6B$3.91B$3.38B$2.51B$2.25B$1.62B$913.59M$720.05M$425.51M$521.44M$797.83M$469.98M$341.39M$343.95M$320.21M$276.95M$394.19M$134.14M$73M$92.9M$99.6M$85M$49.2M$52M$91.8M$84.7M$106.6M$22.4M
Long-Term Assets
Property, Plant & Equipment Net$5.12B$4.6B$4.15B$3.76B$3.48B$3.22B$2.89B$2.58B$2.36B$2.08B$1.59B$974.31M$526.98M$379.94M$367.95M$347.45M$259.68M$87.85M$58.3M$49.35M$60.53M$71.24M$80.72M$76.83M$39.45M$36.93M$36.3M$33M$32.7M$34.3M$27.9M$27.7M$22.4M$10.5M$5.4M$2.2M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$1.26B$1.15B$1.04B$915.5M$6.7M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$1.6M$500K
Long-Term Investments$10.26B$8.9B$5.4B$6.59B$6.84B$3.14B$3.26B$1.75B$1.49B$864.26M$632.16M$460.15M$389.89M$271.23M$275.89M$370.05M$47.08M$51.06M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$4.08B$3.31B$2.58B$1.72B$876.9M$858.9M$824.2M$828.7M$506.29M$825.3M$461.94M$316.1M$231.88M$192.02M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.82B$1.14B$444.1M$336.4M$216.1M$168.1M$144.7M$127.4M$77.9M$20.29M$5.81M$3.03M$5.33M$31.29M$13.96M$14.31M$8.94M$9.68M$1.9M$65.75M$21.57M$57.91M$78.63M$37.8M$61.76M$37.2M$27.7M$31M$36.1M$18.3M$16.7M$14.5M$3.4M$2.7M$400K$300K
Total Long-Term Assets$22.54B$19.1B$13.6B$13.33B$11.42B$7.38B$7.12B$5.29B$4.43B$3.79B$2.69B$1.75B$1.15B$874.48M$657.81M$731.81M$315.69M$202.78M$138.43M$115.11M$82.11M$129.15M$159.35M$114.63M$101.21M$74.13M$64M$64M$68.8M$52.6M$44.6M$42.2M$25.8M$13.2M$7.4M$3M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$40.56B$37.76B$33.08B$29.21B$25.43B$17.16B$14.81B$11.73B$8.76B$6.97B$5.61B$3.87B$2.95B$2.08B$1.32B$1.09B$741.2M$670.04M$936.26M$585.09M$423.5M$473.11M$479.56M$391.57M$495.4M$208.27M$137M$156.9M$168.4M$137.6M$93.8M$94.2M$117.6M$97.9M$114M$25.4M
Liabilities
Current Liabilities
Accounts Payable$939M$789.5M$606.6M$589.2M$564M$475.5M$418.1M$218.2M$178.2M$134.98M$140.96M$99.51M$61.94M$38.93M$27.74M$15.59M$18.64M$6.27M$8.13M$4.35M$4.2M$4.41M$18.93M$30.31M$14.83M$9.45M$6.6M$5.6M$4.7M$4.4M$6.3M$5M$10.3M$2.5M$1.6M$0
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$200M$0$0$0$13.82M$150K$426K$612K$1.4M$1.1M$1.8M$3.6M$3.5M$3.1M$1.6M$1M$400K$0
Current Income Tax Payable$0$213.2M$0$300K$326.3M$19.5M$49.4M$20.8M$227K$235.78M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$553M$627.7M$458.9M$477.9M$442M$577.7M$591.7M$452.5M$320.14M$231.66M$153.49M$74.03M$47M$50.83M$300.25M$54.72M$44.54M$209.93M$44.43M$23.54M$17.02M$15.27M$40.17M$9.66M$6.77M$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0$0$85M$0$0$1.18M$13.56M$97.15M$0$0$0$12.03M$0$0$0$0$2.29M$0$0$0$0$0$5.3M$2.7M$4.2M$4M$3.1M$9.8M$1.2M$1.1M$1.3M$1.8M
Total Current Liabilities$4.37B$3.94B$3.42B$3.14B$3.93B$2.7B$2.1B$1.44B$1.14B$1.24B$811.16M$654.66M$298.83M$163.55M$148.27M$109.06M$93.58M$83.67M$283.66M$45.01M$40.36M$34.14M$72.92M$40.12M$22.02M$13.79M$13.3M$9.4M$10.7M$12M$12.9M$17.9M$13.1M$4.6M$3.3M$1.8M
Long-Term Liabilities
Long-Term Debt$1.99B$1.98B$1.98B$1.98B$1.98B$1.98B$0$0$0$0$0$146.77M$320.31M$296.52M$275.02M$0$0$5.09M$0$200M$200M$200M$200M$200M$200M$1.47M$2.7M$3.1M$3.8M$5.1M$6M$9.2M$5.9M$5.8M$2.4M$0
Long-Term Unearned Revenue$208.7M$185.7M$126.7M$69.8M$73.3M$57.8M$105.3M$464.2M$629.2M$830.77M$664.68M$135.25M$184.2M$208.34M$248.61M$285.86M$137.88M$162.42M$192.33M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$2.02B$1.57B$854.1M$638M$680.2M$687.1M$799.7M$546.6M$949.29M$100.39M$115.53M$217.13M$11.33M$7.26M-$247.6M$52.57M$3.96M$0$0$0$0$0$159K$0$0$10.29M$11.5M$13.2M$15M$13.6M$7M$0$200K$300K$2.1M$11.4M
Total Long-Term Liabilities$4.93B$4.46B$3.68B$3.41B$2.73B$3.44B$1.62B$1.53B$1.48B$1.28B$1.14B$632.76M$700.1M$671.55M$689.58M$452.56M$250.87M$219.03M$192.33M$323.45M$269.14M$256.43M$268.99M$205.47M$207.02M$12.36M$14.2M$16.3M$18.8M$18.7M$13M$9.2M$6.1M$6.1M$4.5M$11.4M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$9.3B$8.41B$7.11B$6.55B$6.67B$6.14B$3.72B$2.98B$2.62B$2.52B$1.95B$1.33B$998.94M$835.11M$837.85M$561.62M$344.44M$251.19M$475.99M$368.47M$309.5M$290.56M$341.91M$245.59M$229.04M$26.14M$27.5M$25.7M$29.5M$30.7M$25.9M$27.1M$19.2M$10.7M$7.8M$13.2M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$100K$100K$100K$100K$100K$100K$100K$100K$112K$110K$108K$104K$99K$97K$93K$89K$81K$80K$79K$65K$56K$56K$55K$44K$44K$37K$0$0$0$0$0$0$0$0$0$0
Retained Earnings$35.8B$31.67B$27.26B$23.31B$18.97B$10.89B$7.38B$5.25B$2.95B$1.75B$852.7M$255.38M-$92.69M-$517.05M-$1.27B-$1.05B-$941.1M-$875.93M-$793.22M-$687.62M-$585.28M-$489.83M-$531.53M-$424.07M-$299.7M-$223.52M-$200.3M-$177.2M-$168.6M-$157M-$124.6M-$101.1M-$70.4M-$30.6M-$11.4M-$7M
Comprehensive Income & Other$77.5M-$7.9M-$80.9M-$238.8M-$26.2M$29.3M$21.1M-$12.3M$640K-$12.84M$8.57M$52.25M-$1.19M-$1.17M-$1.86M-$2.49M$1.04M-$114K$170K-$231K-$785K-$3.07M-$4M-$3.17M-$1.61M-$780K-$500K-$26.6M-$23.6M-$5.9M-$5.9M$0$0$0$0$0
Other Stockholders' Equity-$4.54B-$2.32B-$1.29B-$642.8M-$199.6M$132.2M$3.71B$3.5B$3.2B$2.7B$2.8B$2.29B$2.04B$1.76B$1.75B$1.57B$1.34B$1.29B$1.25B$904.18M$699.23M$672.32M$669.12M$570.01M$566.01M$405.61M$309.8M$308.4M$307.5M$263.9M$192.5M$168.2M$168.8M$117.8M$117.6M$19.2M
Total Equity$31.26B$29.35B$25.97B$22.66B$18.77B$11.03B$11.09B$8.76B$6.14B$4.45B$3.65B$2.54B$1.95B$1.25B$485.73M$527.82M$396.76M$418.85M$460.27M$216.62M$114M$182.54M$137.64M$145.98M$266.36M$182.13M$109.5M$131.2M$138.9M$106.9M$67.9M$67.1M$98.4M$87.2M$106.2M$12.2M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$40.56B$37.76B$33.08B$29.21B$25.43B$17.16B$14.81B$11.73B$8.76B$6.97B$5.61B$3.87B$2.95B$2.08B$1.32B$1.09B$741.2M$670.04M$936.26M$585.09M$423.5M$473.11M$479.56M$391.57M$495.4M$208.27M$137M$156.9M$168.4M$137.6M$93.8M$94.2M$117.6M$97.9M$114M$25.4M
Supplementary Data
Total Debt$2.71B$2.7B$2.7B$2.7B$2.7B$2.7B$713.9M$708.5M$703.45M$481.13M$375.51M$459.06M$505.51M$457.33M$435.53M$160.03M$109.02M$5.09M$202.29M$200M$200M$200M$213.82M$200.15M$200.58M$2.68M$4.1M$4.2M$5.6M$8.7M$9.5M$12.3M$7.5M$6.8M$2.8M$0
Net Debt-$412.2M$216.2M-$27.1M-$404.5M-$185.9M$502M-$903.9M-$759.2M-$109.28M-$54.08M-$433.59M-$189.66M-$30.1M$227.05M-$48.08M$47.46M-$98.05M-$242.7M-$296.63M-$37.88M$15.49M$98.77M$95.53M$120.07M-$46.82M-$28.3M-$19.6M-$15.6M-$23.3M-$25.8M-$23.2M-$11.3M-$5M-$9.6M-$23.4M-$21.8M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997FY 1996FY 1995FY 1994FY 1993FY 1992FY 1991
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-31
Operating Activities
Net Income$4.5B$4.41B$3.95B$4.34B$8.08B$3.51B$2.12B$2.44B$1.2B$895.52M$636.06M$348.07M$424.36M$750.27M-$221.76M-$104.47M-$67.83M-$82.71M-$105.6M-$102.34M-$95.45M$41.7M-$107.46M-$124.38M-$76.18M-$23.21M-$23.1M-$8.6M-$11.6M-$32.4M-$23.5M-$30.7M-$39.9M-$19.1M-$4.5M
Depreciation & Amortization$543.7M$482.9M$421M$341.4M$286.2M$235.9M$210.3M$148.2M$145.47M$104.75M$74.91M$52.69M$41.2M$36.94M$31.08M$19.69M$14.25M$11.29M$11.49M$14.59M$15.5M$15.36M$12.94M$8.45M$6.08M$4.42M$3.4M$3M$4.4M$6.1M$5.9M$4.2M$3.1M$2M$800K
Deferred Income Tax-$785.4M-$757.3M-$837.8M-$746.4M-$147.1M$75.6M-$130.6M-$140M$318.81M-$360.08M-$121.62M-$66.6M$63.6M-$340.16M$0$0-$56K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$993.7M$982.8M$885M$725M$601.7M$432M$464.3M$427.4M$507.28M$559.88M$459.05M$307.24M$198.4M$94.16M$56.09M$39.9M$31.26M$32.52M$28.07M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$498.1M-$554M-$338.8M$707.8M-$1.93B-$1.36B-$473.1M-$268.9M-$362.72M-$143.83M-$491.42M-$62.43M-$198.66M-$590.09M-$21.12M-$27.54M-$30.36M-$16.89M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory-$275.3M-$619.7M-$271.7M-$696.5M-$494.3M-$529.4M-$335.5M-$387.9M-$314.19M-$149.78M-$111.83M-$60.9M-$47.96M-$52.62M$0$0-$4.57M$0$0$3.59M$1.25M$6.91M-$1.05M-$1.73M-$941K$4.05M-$4M$0$0$0$0$0$0$0$0
  Accounts Payable$736.8M$735.1M$598.6M-$138.4M$866.1M$118.9M$444.5M$210M-$23.19M$253.98M$303.66M$162.24M$136.68M$10.98M$0$0$12.96M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital-$427M-$179.7M-$82.2M-$116.2M-$360.9M$263M$163.6M-$250.2M-$226.43M$267.81M$529.42M-$18.66M-$80.74M-$41.08M$3.65M$168.48M-$27.5M-$35.54M$87.47M$89.36M$26.54M-$65.66M$85.38M$5.31M$11.96M-$19.3M$5.2M-$7.4M-$2.6M-$8.5M-$14.8M$0$0$0$0
Total Working Capital Change$532.6M-$618.3M-$94.1M-$243.3M-$1.92B-$1.5B-$200.5M-$697M-$926.53M$228.19M$229.83M$20.24M-$190.67M-$672.8M-$17.46M$140.94M-$49.47M-$52.43M$87.47M$92.96M$27.79M-$58.74M$84.33M$3.58M$11.02M-$15.25M$1.2M-$7.4M-$2.6M-$8.5M-$14.8M-$3M$3.1M$1.5M-$600K
Other Non-Cash Items-$810.6M-$82.2M$266.3M$599.8M$181.7M-$135M-$29.3M$12.1M$63.57M$57.64M$52.56M$19.63M$45.34M$56.97M$10.37M$293K-$382K$2.25M$5.94M$17.86M$21.86M-$15.23M$4.06M$1.82M$1.77M$6.14M$4.7M$2.8M$3.7M$14.5M$14.2M$9M$3.6M-$1.6M-$2.5M
Net Cash from Operating$4.98B$4.42B$4.59B$5.01B$7.08B$2.62B$2.43B$2.2B$1.31B$1.49B$1.33B$752.43M$588.6M-$74.61M-$141.68M$96.34M-$72.23M-$89.09M$27.37M$23.07M-$30.3M-$16.91M-$6.13M-$110.52M-$57.32M-$27.91M-$13.8M-$10.2M-$6.1M-$20.3M-$18.2M-$20.5M-$30.1M-$17.2M-$6.8M
Investing Activities
Capital Expenditures-$1.21B-$755.9M-$926.4M-$590.1M-$551.9M-$614.6M-$429.6M-$383.1M-$272.6M-$511.9M-$677.93M-$333.01M-$156.32M-$49.34M-$57.22M-$99.69M-$97.32M-$34.86M-$18.45M-$2.81M-$4.96M-$6.17M-$29.66M-$34.37M-$8.22M-$6.5M-$5.7M-$3M-$2.1M-$8.6M-$3.3M-$6.9M-$10.2M-$2.1M-$1M
Acquisitions-$3.3M-$16.5M-$54.9M-$230.3M$551.9M$614.6M$429.6M$1.07B$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$10.96B-$16.62B-$11.65B-$7.49B-$7.05B-$3.24B-$3.2B-$1.85B-$1.28B-$809.42M-$557.11M-$564.19M-$577.28M-$470.39M-$240.39M-$612.19M-$200M-$581.14M-$594.45M-$456.89M-$102.99M-$276.32M-$287.5M-$239.98M-$191.35M-$104.9M-$60.1M-$88M-$112.6M-$74.6M-$28.1M-$22.5M-$77.3M-$71.6M-$137.2M
Sales of Investments$11.55B$15.03B$9.44B$5.55B$2.22B$3.79B$1.6B$775.6M$544.58M$274.46M$327.44M$476.42M$378.15M$439.21M$426.36M$276.6M$297.41M$646.86M$527.17M$306.2M$223.45M$277.91M$253.31M$215.83M$124.19M$53.72M$83.2M$93.5M$75.9M$38.9M$38.8M$61.3M$68.5M$82.8M$61.8M
Other Investing Activities$0-$105.6M$0-$1.03B-$551.9M-$614.6M-$429.6M-$1.08B-$26K-$41K$0$0$0-$552K-$277K$1.12M$50K-$50K$0-$1.6M$0$0$0$0$0$0$100K-$100K-$100K$0$0$0-$4.6M-$900K-$1.2M
Net Cash from Investing-$629.1M-$2.47B-$3.19B-$3.78B-$5.38B-$70.6M-$2.03B-$1.46B-$1.01B-$1.05B-$907.6M-$420.78M-$355.45M-$81.07M$128.47M-$434.15M$146K$30.82M-$85.72M-$155.1M$115.49M-$4.58M-$63.84M-$58.52M-$75.39M-$57.68M$17.5M$2.4M-$38.9M-$44.3M$7.4M$31.9M-$23.6M$8.2M-$77.6M
Financing Activities
Debt Repaid------$1.98B---$37.1M$40.6M$140.45M$221.73M$2.02M$2.2M-$389.44M-$46.52M-$22.77M$200.81M----$3.83M-$13.51M$426K-$190.6M$1.5M$1.1M$1.9M$3.9M$3.7M$3.3M$300K$1.2M$800K$100K
Common Stock Issuance$635.9M$1.47B$1.15B$1.52B$1.67B$2.58B$211.8M$114.5M$240.21M$126.74M$206.36M$126.05M$57.39M$63.55M$18.51M$200.59M$8.6M$7.95M$319.4M$185.01M$4.08M$1.5M$94.68M$2.15M$158.52M$94.36M$1.4M$500K$43.4M$70M$23.2M$0$51.1M$0$91.6M
Common Stock Repurchases-$3.97B-$3.63B-$2.23B-$2.53B-$2.68B-$6.53B-$463.9M-$191.6M-$301.7M-$143.2M-$160.54M-$267.58M-$195.09M-$163.3M-$25.08M-$3.8M$0$0$0$0$0-$888K$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid-$370.3M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$10.3M-$33.4M-$700.6M-$445.7M-$1.03B$2.58B-$188M-$187.2M$0-$516.59M-$168.17M$144.73M$16.82M$4.31M-$23.7M$0$0$0$0$390K$0$0$0$0$0$0$0$0-$100K$0$0$100K-$100K$0$0
Net Cash from Financing-$3.72B-$2.2B-$1.79B-$1.01B-$1.01B-$1.97B-$252.1M-$77.1M-$24.4M-$700.39M-$262.8M-$218.55M$72.19M-$97.65M$384.25M$243.31M$31.36M-$192.86M$319.4M$185.4M$4.08M$4.44M$108.18M$1.72M$349.12M$92.87M$300K-$1.4M$39.4M$66.3M$19.9M-$200K$49.8M-$800K$91.5M
Forex Effect$300K-$700K-$400K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$100K$0$0$0$0$0$0$0$0
Net Change in Cash$634.7M-$248.8M-$381.6M$221.3M$690.8M$577M$150.1M$655M$277.53M-$273.9M$160.38M$113.11M$305.33M-$253.33M$371.04M-$94.5M-$40.72M-$251.13M$261.05M$53.37M$89.28M-$17.05M$38.21M-$167.32M$216.41M$7.28M$3.9M-$9.2M-$5.6M$1.7M$9.1M$11.2M-$3.9M-$9.8M$7.1M
Supplementary Data
Operating Cash Flow$4.98B$4.42B$4.59B$5.01B$7.08B$2.62B$2.43B$2.2B$1.31B$1.49B$1.33B$752.43M$588.6M-$74.61M-$141.68M$96.34M-$72.23M-$89.09M$27.37M$23.07M-$30.3M-$16.91M-$6.13M-$110.52M-$57.32M-$27.91M-$13.8M-$10.2M-$6.1M-$20.3M-$18.2M-$20.5M-$30.1M-$17.2M-$6.8M
Capital Expenditure-$898.4M-$755.9M-$926.4M-$590.1M-$551.9M-$614.6M-$429.6M-$383.1M-$272.6M-$511.9M-$677.93M-$333.01M-$156.32M-$49.34M-$57.22M-$99.69M-$97.32M-$34.86M-$18.45M-$2.81M-$4.96M-$6.17M-$29.66M-$34.37M-$8.22M-$6.5M-$5.7M-$3M-$2.1M-$8.6M-$3.3M-$6.9M-$10.2M-$2.1M-$1M
Free Cash Flow$4.08B$3.66B$3.67B$4.42B$6.53B$2B$2B$1.81B$1.03B$974M$652.85M$419.43M$432.27M-$123.95M-$198.9M-$3.35M-$169.55M-$123.94M$8.93M$20.26M-$35.26M-$23.08M-$35.79M-$144.89M-$65.54M-$34.41M-$19.5M-$13.2M-$8.2M-$28.9M-$21.5M-$27.4M-$40.3M-$19.3M-$7.8M
Cash at Beginning$2.49B$2.74B$3.12B$2.9B$2.21B$1.63B$1.48B$825.2M$535.2M$809.1M$648.72M$535.61M$230.28M$483.61M$112.57M$207.07M$247.8M$498.93M$237.88M$184.51M$95.23M$118.28M$80.08M$247.39M$30.98M$23.7M$19.8M$28.9M$34.5M$32.7M$23.6M$12.5M$16.4M$26.2M$19.2M
Cash at End$3.12B$2.49B$2.74B$3.12B$2.9B$2.21B$1.63B$1.48B$812.73M$535.2M$809.1M$648.72M$535.61M$230.28M$483.61M$112.57M$207.07M$247.8M$498.93M$237.88M$184.51M$101.23M$118.28M$80.08M$247.39M$30.98M$23.7M$19.7M$28.9M$34.4M$32.7M$23.7M$12.5M$16.4M$26.3M